Sonnet BioTherapeutics Holdings Inc Ordinary Shares (NASDAQ:SONN)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - SONN
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - SONN
- Market Cap$41.740m
- SymbolNASDAQ:SONN
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS83548R1059
Company Profile
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
Latest SONN news
Currently there for this company. Visit our news hub for other news .